Detalhe da pesquisa
1.
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study.
Lancet Oncol
; 25(3): 388-399, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423051
2.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Haematologica
; 108(1): 34-41, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678031
3.
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.
Ann Hematol
; 100(6): 1497-1508, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33914097
4.
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia.
Cancers (Basel)
; 15(8)2023 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190195
5.
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study.
Cancers (Basel)
; 14(8)2022 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35454828
6.
Management of acquired hemophilia A: results from the Spanish registry.
Blood Adv
; 5(19): 3821-3829, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34521101